FDA Drug Approval Package – Fluvoxamine Maleate ER Capsules (ANDA #091482)

FDA Drug Approval Package – Fluvoxamine Maleate ER Capsules (ANDA #091482)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: FDA drug approval package for Fluvoxamine Maleate ER Capsules 100 mg and 150 mg developed by Actavis Elizabeth LLC, ANDA #091482
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details